v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash Flows from Operating Activities            
Net income       $ 21,375 $ 14,662  
Adjustments to reconcile net income to net cash from operating activities:            
Depreciation       1,963 1,971  
Amortization (accretion) of premiums and discounts on available-for-sale securities, net       (207) 113  
Capitalized additions to servicing rights       (761) (515)  
Servicing rights amortization and impairment $ 328   $ 234 851 361  
Amortization of core deposit intangible       548 828  
Amortization of customer list intangible       61 61  
Net accretion of fair value adjustments       (792) (1,177)  
Amortization of subordinated note issuance costs       58 57  
Stock-based compensation expense       716 744  
Director stock awards       188 181  
Provision for credit losses - loans 173   661 475 1,472 $ 2,596
Provision for (recovery of) credit losses - off balance sheet credit exposures 148   27 154 (233)  
Gain on sale of loans held for sale (683)   (257) (1,258) (541)  
Originations of loans held for sale       (49,435) (30,158)  
Proceeds from sale of loans held for sale       51,633 27,336  
(Gain) loss on derivatives       32 (22)  
(Gain) loss on sale of other assets owned (30)   (15) (30) 39  
Loss on sales of securities available-for-sale       347 0  
Increase in cash surrender value of bank owned life insurance       (1,336) (483)  
Change in other assets and other liabilities, net       (6,130) (2,583)  
Net cash provided by operating activities       18,452 12,113  
Activity in available-for-sale securities:            
Maturities, prepayments and calls       45,140 32,785  
Sales   $ 5,400   5,354 0  
Purchases       (72,434) (29,831)  
Activity in other securities, at cost:            
Purchases of FHLB stock       (521) (472)  
Proceeds from redemption of FHLB stock       2,872 878  
Purchase of bank owned life insurance       (2,500) 0  
Proceeds from bank owned life insurance       3,226 0  
Change in interest-bearing time deposits       980 490  
Proceeds from sale of other assets owned       977 15  
Additions to premises and equipment       (872) (1,105)  
Net decrease (increase) on loan originations and principal collections       7,561 (63,268)  
Net cash used in investing activities       (10,217) (60,508)  
Cash Flows from Financing Activities            
Net change in deposits       138,673 23,564  
Net change in federal funds purchased and securities sold under agreements to repurchase       (22,947) 344  
Proceeds from FHLB advances       32,180  
Repayment of FHLB advances       (91,117) (57,617)  
Purchase of treasury stock       (99) (23)  
Cash dividends paid on common stock       (6,253) (5,993)  
Net cash provided by (used in) financing activities       50,437 (39,725)  
Net Increase (Decrease) in Cash and Cash Equivalents       58,672 (88,120)  
Cash and Cash Equivalents - Beginning of year   $ 97,718   97,718 176,351 176,351
Cash and Cash Equivalents - End of period $ 156,390   $ 88,231 156,390 88,231 $ 97,718
Supplemental cash flow information:            
Interest paid       33,452 34,859  
Federal income taxes paid       5,300 4,410  
State income taxes paid       335 177  
Supplemental noncash disclosures:            
Transfer of loans to other real estate owned       319 0  
Cash dividends declared not paid       $ 3,130 $ 3,000